Berkshire Hathaway, the US investor Warren Buffett’s investment fund, has made new investments in Pfizer and Merck. Berkshire also deployed funds to pharmaceutical AbbVie and Bristol-Myers Squibb. At the same time, billionaire lowered its interests in financial companies, including Wells Fargo and JPMorgan Chase, as evidenced by third-quarter documents.
Berkshire had already started buying shares in health companies before Pfizer announced last week that its candidate vaccine was 90% effective in clinical trials. Merck supports the study of more than 50 potential SARSv2 vaccines and is also investigating a medicine for the treatment of COVID-1`9 pneumonia.
At the end of the third quarter in AbbVie, Bristol-Myers Squibb and Merck each Buffet had a stake of more than USD 1.8 billion and about USD 136 million in Pfizer. The investment company reduced the interest in Wells Fargo slightly, and reduced the investment in JPMorgan by as much as 96 percent.
Buffett’s been known to shake up his stock portfolio. For example, earlier this year, the investor sold out all his shares in four major airlines.